(1) Where an Inspector takes any sample of a drug 1[or cosmetic] under this Chapter, he shall tender the fair price thereof and may require a written acknowledgment therefor.
(2) Where the price tendered under sub-section (1) is refused, or where the Inspector seizes the stock of any drug 1[or cosmetic] under clause (c) of section 22, he shall tender a receipt therefor in the prescribed form.
(3) Where an Inspector takes a sample of a drug 1[or cosmetic] for the purpose of test or analysis, he shall intimate such purpose in writing in the prescribed form to the person from whom he takes it and, in the presence of such person unless he wilfully absents himself, shall divide the sample into four portions and effectively seal and suitably mark the same and permit such person to add his own seal and mark to all or any of the portions so sealed and marked:
Provided that where the sample is taken from premises whereon the drug 1[or cosmetic] is being manufactured, it shall be necessary to divide the sample into three portions only:
Provided further that where the drug 1[or cosmetic] is made up in containers of small volume, instead of dividing a sample as aforesaid, the Inspector may, and if the drug 1[or cosmetic] be such that it is likely to deteriorate or be otherwise damaged by exposure shall, take three or four, as the case may be, of the said containers after suitably ma rking the same and, where necessary, sealing them.
(4) The Inspector shall restore one portion of a sample so divided or one container, as the case may be, to the person from whom he takes it, and shall retain the remainder and dispose of the same as follows:-
(i) one portion or container he shall forthwith send to the Government Analyst for test or analysis;
(ii) the second, he shall produce to the Court before which proceedings, if any, are instituted in respect of the drug 1[or cosmetic]; and
2[(iii) the third, where taken, he shall send to the person, if any,
whose name, address and other particulars have been disclosed under section
18A.]
(5) Where an Inspector takes any action under clause (c) of section 22,-
(a) he shall use all despatch in ascertaining whether or not the drug 1 or cosmetic; contravenes any of the provisions of section 18 and, if it is ascertained that the drug 1[or cosmetic]; does not so contravene, forthwith revoke the order passed under the sa id clause or, as the case may be, take such action as may be necessary for the return of the stock seized;
(b) if he seizes the stock of the drug 1[or cosmetic]; he shall as soon as may be inform 3[a Judicial Magistrate] and take his orders as to the custody thereof;
(c) without prejudice to the institution of any prosecution, if the alleged contravention be such that the defect may be remedied by the possessor of the drug 4[or cosmetic]; he shall, on being satisfied that the defect has been so remedied, forthwith revoke his order under the said clause.
5[(6) Where an Inspector seizes any record, register, document or any other material object under clause (cc) of sub-section (1) of section 22, he shall, as soon as may be, inform 6[a Judicial Magistrate] and take his orders as to the custody thereof.
----------------
1. Ins. by Act 21 of 1962, s. 15 (w.e.f. 27-7-1964).
2. Subs. by Act 13 of 1964, s. 16, for cl. (iii) (w.e.f. 15-9-1964).
3. Subs. by Act 68 of 1982, s. 20, for "a Magistrate" (w.e.f. 1-2-1983).
4. Ins. by Act 21 of 1962, s. 15 (w.e.f. 27-7-1964).
5. Ins. by Act 35 of 1960, s. 6 (w.e.f. 16-3-1961).
6. Subs. by Act 68 of 1982, s. 20, for "a Magistrate" (w.e.f. 1-2-1983).
Section 16 Standards of quality
Section 17C Misbranded cosmetics
Section 17D Spurious cosmetics
Section 17E Adulterated cosmetics
Section 18 Prohibition of manufacture and sale of certain drugs and cosmetics
Section 18A Disclosure of the name of the manufacturer, etc
Section 18B Maintenance of records and furnishing of information
Section 20 Government Analysts
Section 22 Powers of Inspectors
Section 23 Procedure of Inspectors
Section 24 Persons bound to disclose place where drugs or cosmetics are manufactured or kept
Section 25 Reports of Government Analysts
Section 26 Purchaser of drug or cosmetic enabled to obtain test or analysis
Section 27 Penalty for manufacture, sale, etc., of drugs in contravention of this Chapter
Section 27A Penalty for manufacture, sale, etc., of cosmetics in contravention of this Chapter
Section 28 Penalty for non-disclosure of the name of the manufacturer, etc
Section 28A Penalty for not keeping documents, etc., and for non-disclosure of information
Section 28B Penalty for manufacture, etc., of drugs or cosmetics in contravention of section 26A
Section 29 Penalty for use of Government Analyst's report for advertising